AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Pluri Inc.

Regulatory Filings Nov 6, 2020

6990_rns_2020-11-05_cededfbe-b01d-4477-996d-22a83efad1f8.htm

Regulatory Filings

Open in Viewer

Opens in native device viewer

_________ false

�������� ��������� ���� 2 379
PLURISTEM THERAPEUTICS INC
Corporation no: C12337-2001 8543
- - -
Israel Securities Authority Tel Aviv Stock Exchange C001 ( Public ) Reported via MAGNA: 05/11/2020
www.isa.gov.il www.tase.co.il Reference: 2020-02-110881 Time of broadcast: 23:08 23:08

Report of Periodic or Interim ReportRegulation 3 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onPSTI 10Q September 30 2020

PSTI_10Q_September_30_2020_isa.pdf

Link to filing on foreign stock exchange (optional): _________

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NASDAQ CM Date of revision of form structure: 27/10/2020
Address: Matam Park 5 , Haifa 31905   ISRAEL , Tel: 074-7107171 , Fax: 074-7107172
E-mail address: [email protected]   Company site: www.pluristem.com
Previous names of reporting entity:
Name of the Signatory: Yanay Yaacov Position of Signatory in the reporting corporation: Chief Executive Officer, Director Name of Employer Company:
Address: Matam Park 5 , Haifa 31905 Telephone: 074-7107171 Facsimile: 074-7108673 E-mail: [email protected] 1

Talk to a Data Expert

Have a question? We'll get back to you promptly.